These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Prevention of graft-vs.-host disease. Woods WG Am J Pediatr Hematol Oncol; 1984; 6(3):283-6. PubMed ID: 6393792 [TBL] [Abstract][Full Text] [Related]
13. Potential usefulness of photochemotherapy using 8-methoxypsoralen in the treatment of posttransfusion graft-versus-host disease. Nishimura M; Akaza T; Tadokoro K; Juji T Vox Sang; 1998; 75(4):306-7. PubMed ID: 9873267 [No Abstract] [Full Text] [Related]
14. Treatment of acute post-transfusion- graft-versus-host disease (GVHD) with intravenous human immunoglobulins: a case report. Orlandi C; Frassetto A; Gnucci E; Lehmann JR; Neri R; Melandri D J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):760-1. PubMed ID: 16836524 [No Abstract] [Full Text] [Related]
15. Graft-vs-host disease after solid organ transplant. Gulbahce HE; Brown CA; Wick M; Segall M; Jessurun J Am J Clin Pathol; 2003 Apr; 119(4):568-73. PubMed ID: 12710129 [TBL] [Abstract][Full Text] [Related]
16. [Possible involvement of donor-derived B cells in development of post-transfusion graft-versus-host disease]. Nishimura M; Akaza T; Tadokoro K; Juji T Nihon Rinsho; 1997 Sep; 55(9):2246-51. PubMed ID: 9301284 [TBL] [Abstract][Full Text] [Related]
18. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force. Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157 [No Abstract] [Full Text] [Related]
19. Post-transfusion graft-versus-host disease following open heart surgery. Report of six cases. Sakakibara T; Ida T; Mannouji E; Kikuchi T; Tatsuno K; Kawase M; Imai M J Cardiovasc Surg (Torino); 1989; 30(4):687-91. PubMed ID: 2528550 [TBL] [Abstract][Full Text] [Related]
20. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft. Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]